Elite Pharmaceuticals Inc (ELTP)

[guti]

That's where the issue comes into play. The FDA wants to approve drugs that do deter over dosing. However, when raising the bar to that standard, where do you begin to determine the approaval of a drug that builds tolerance with time or that if not administered correctly can damage an organ? Let's keep in mind that those types of drugs are normally intended to be prescribed for patients in need of short term or last resort help.